The Chrna5 gene encodes the ␣5 nicotinic acetylcholine receptor subunit, an "accessory" subunit of pentameric nicotinic receptors, that has been shown to play a role in nicotine-related behaviors in rodents and is genetically linked to smoking behavior in humans. Here we have used a BAC transgenic mouse line, ␣5 GFP , to examine the cellular phenotype, connectivity, and function of ␣5-expressing neurons. Although the medial habenula (MHb) has been proposed as a site of ␣5 function, ␣5
Introduction
Among behavioral health disorders, nicotine addiction is one of the largest global causes of morbidity and mortality (World Health Organization, 2008) . Twin studies have estimated that the heritability of smoking is 50 -75% (Hall et al., 2002) , but the genetic basis of this complex disorder is elusive. Recent genomewide association studies have identified a risk haplotype for nicotine addiction in European populations encompassing the three clustered nicotinic acetylcholine receptor (nAChR) genes CHRNA3, CHRNA5, and CHRNB4 (Berrettini and Doyle, 2012) , which encode the ␣3, ␣5, and ␤4 nAChR subunits, respectively. The most common haplotype identified in these studies includes a nonsynonymous single-nucleotide polymorphism in the CHRNA5 gene, D398N, which may affect receptor function (Kuryatov et al., 2011) . Consistent with a role for the ␣5 subunit in nicotine addiction, mice with null mutations of the Chnra5 gene exhibit altered behavioral responses to nicotine, including resistance to nicotine-induced seizures, reduced withdrawal after chronic administration, and increased self-administration at high doses (Salas et al., 2003 (Salas et al., , 2009 Fowler et al., 2011) . Thus, the sites of expression and function of the ␣5 subunit in the brain will help to define neural pathways governing nicotine-mediated behaviors.
Chrna3 and Chrnb4 are transcribed on the same chromosomal strand, are frequently coexpressed, and together form a pentameric receptor with pharmacology that is distinctive from the more widely expressed receptors containing ␣4 and ␤2 subunits (Quick et al., 1999) . The expression of ␣3 and ␤4 is limited to a few areas of the CNS, with the highest levels of mRNA observed in the medial habenula (MHb; Marks et al., 1992) . Chrna5 is transcribed on the opposite strand of the gene cluster, and ␣5 mRNA is expressed at high levels in the principal target of MHb efferents, the interpeduncular nucleus (IP). The ␣5 subunit is an "accessory" subunit that forms functional receptor channels only in combination with other ␣-and ␤-subunits, including ␣4␤2 (Ramirez- Latorre et al., 1996) , ␣3␤4, and ␣3␤3 .
Here we have used a BAC transgenic line, ␣5 GFP , to reveal the anatomical and functional properties of ␣5 neurons in the habe-nula-interpeduncular-raphe pathway. Expression of ␣5 GFP is undetectable in the MHb, and endogenous ␣5 mRNA is also expressed at very low levels there, but both are robustly expressed in the IP. The ␣5-expressing neurons in the IP are exclusively GABAergic, and they project primarily to the median raphe (MnR), paramedian raphe (PMnR), and dorsal tegmental area (DTg), where they terminate near 5-HT neurons in the caudal dorsal raphe (DRC) and interfascicular dorsal raphe (DRI). The ␣5-expressing IP neurons receive direct synaptic input from cholinergic neurons of the ventral MHb (vMHb) and exhibit nicotinic pharmacology consistent with ␣5 incorporation into both postsynaptic IP ␣4␤2 and ␣3␤4 receptors. Although two recent studies have proposed that ␣5 mediates behavioral effects via expression in the MHb (Fowler et al., 2011; Frahm et al., 2011) , our results do not support a major role for ␣5 in the MHb in mice. Instead, they suggest that the physiological effects of ␣5 in the MHb pathway are mediated through GABAergic interneurons in the IP and raphe.
Materials and Methods

Animals. The ␣5
GFP BAC transgenic line Tg(Chrna5-EGFP)IG16Gsat/ Mmucd was generated by the GENSAT Project and obtained as cryogenically preserved sperm from the Mutant Mouse Regional Resource Center at the University of California, Davis. Recovery of live animals by in vitro fertilization of oocytes from C57BL/6NCrl (Charles River) mice was performed by the University of Washington Transgenic Resources Program. This BAC transgene interrupts the ␣5 nicotinic receptor transcription unit and produces a cytoplasmic GFP; it does not express mRNA encoding ␣5 nicotinic receptors, and it does not disrupt the native genomic Chrna5 gene. The mouse line B6;129S6-Chat tm1(cre)Lowl (Chat Cre ), expressing Cre recombinase from an internal ribosome entry site in the Chat gene 3Ј-untranslated region (3Ј-UTR), was obtained from the The Jackson Laboratory. The optogenetic lines Ai27, conditionally expressing a ChR2(H134R)-tdTomato fusion protein, and Ai32, conditionally expressing a ChR2-EYFP fusion protein, have been described previously (Madisen et al., 2012) . The Cre-driver and optogenetic effector transgenic lines were backcrossed to C57BL/6NCrl, maintained separately on this genetic background, and interbred to produce F1 experimental animals.
Genotyping of transgenic mice was performed using real-time PCR with the following forward (F) and reverse (R) primer pairs: GENSAT ␣5 GFP BAC transgene, F: ATCACTCTCGGCATGGACGA, R: TAGAAG GCACAGTCGAGGCT; Chat Cre allele, F: CCTTCTATCGCCTTCTTGA CG, R: AGATAGATAATGAGGGGCTC; Chat wild-type locus, F: CCAA CCAAGCCAAGCAATCT, R: ATAGGGGAGCAGCAACAGC; Ai27 and Ai32 Rosa26 locus common primer, F: TCGTGATCTGCAACTCCA GTCTT; Rosa26 modified locus-specific primer, R: TGGGCTATGA ACTAATGACCCC; Rosa26 WT locus-specific primer, R: CGCCCA CACACCAGGTTAG.
Quantitative PCR. Quantitative PCR (qPCR) was performed for the ␣3, ␣5, and ␤4 acetylcholine receptor and phosphoglycerate kinase 1 (Pgk1) transcripts. Relative mRNA levels are inversely proportional to the PCR cycle number and were calculated by the cycle threshold difference method (Livak and Schmittgen, 2001 ). All receptor mRNA levels were normalized to Pgk1 mRNA expression in each cell type to correct for small variations in mRNA content between the samples. Primers included ␣3 primers spanning exons 4 and 5, F: TCGTGCTTTACAAC AACGCC, R: CAAACGGGAAGTAGGTCACATC; ␣5 primers spanning exons 2 and 3, F: TTCGTCCTGTGGAACACCTG, R: GGTGGTCATT AGCTGGTTTTTCT; ␤4 primers spanning exons 2 and 3, F: TGGATG ATCTCCTGAACAAAACC, R: GTTCTCGCTCATTCACACTGAT; and Pgk1 primers spanning exons 5 and 6, F: GATGCTTTTGGGACTGCA CA, R: GCAGATTCACACCCACCATG.
Microarray analysis was performed on RNA samples from embryonic day 16.5 (E16.5) mouse embryos using Affymetrix 430v2 arrays as described previously (Quina et al., 2009 ). The ␣5 coding sequence (CDS) in situ hybridization (ISH) probe was Thermo Fisher Scientific/Open Biosystems clone ID number 40046382 (708 bp), corresponding to positions 827-1534 of the ␣5 reference mRNA sequence (GenBank accession number NM_176844_4). The ␣5 3Ј-untranslated ISH probe, corresponding to positions 1549 -2511 of the reference mRNA sequence, was generated by RT-PCR. The ISH probe for ␤4 was a gift from Dr. Silke Frahm-Barske (Max Delbrueck Centrum, Berlin, Germany) (Frahm et al., 2011) . Double-label fluorescence in situ hybridization (DFISH) was performed on a high-throughput platform as described previously (Thompson et al., 2008) . Sequences used to generate FISH probes for Gad1, Slc17a6, Chrna5, and Sst are the same as those used to generate ISH data for the Allen Mouse Brain Atlas (ABA) and are available online at: http://mouse.brain-map.org/search/index.
Tract tracing and immunofluorescence. Retrograde tract tracing was performed using a 1% solution of cholera toxin B subunit (CTB; List Biological Labs), injected using standard stereotaxic coordinates (Paxinos and Franklin, 2001) . Large areal injections of CTB were performed by pressure injection using a 33 ga stainless steel needle, whereas small focal injections were performed by iontopheresis using a pulled glass pipette, using published methods (Harris et al., 2012) . Antibodies for immunofluorescence were obtained from the following sources: rabbit anti-GFP (1:500), Invitrogen; goat anti-GFP (1:500), Thermo Fisher Scientific/ Pierce; chicken anti-GFP (1:500), Aves Labs; goat anti-choline acetyltransferase (ChAT; 1:100), rat monoclonal anti-substance P (SP; 1:200), rabbit anti-tyrosine hydroxylase (1:500), and rabbit anti-tryptophan hydroxylase 2 (Tph2; 1:500), Millipore; goat anti-CTB (1:1000), List Biological Labs; rabbit anti-CTB (1:1000), Abcam; rabbit anti-calretinin (1: 500) and rabbit anti-parvalbumin (1:500), Swant; and rabbit antisomatostatin (1:500), Bachem/Peninsula Labs. Preparation and use of rabbit (Fedtsova and Turner, 1995) and guinea pig (Quina et al., 2005) antisera to mouse Brn3a have been described previously.
Electrophysiology methods. Adult mice of both genders (8 -30 weeks of age) were used for electrophysiology. For the preparation of acute brain slices used in loose-seal cell-attached recordings, mice were anesthetized with isoflurane and quickly decapitated, and the whole brains were dissected into cold artificial CSF (aCSF) containing (in mM) 118 NaCl, 3 KCl, 25 NaHCO 3 , 1 NaH 2 PO 4 , 1 MgCl 2 , 1.5 CaCl 2 , and 10 glucose, pH 7.4. Coronal brain slices (350 m) were cut with a vibratome (VT1000S; Leica) in cold oxygenated aCSF, and slices were allowed to recover for at least 30 min at room temperature in oxygenated aCSF before transferring to the recording chamber. During recording, slices were superfused with aCSF at 30°C.
For the preparation of acute brain slices used in intracellular recordings, mice were anesthetized with isoflurane, injected intraperitoneally with pentobarbital (120 mg/kg), and perfused transcardially with ϳ10 ml of ice-cold oxygenated sucrose slicing solution (SSS). The SSS contained (in mM) 210 sucrose, 5 KCl, 1.25 NaH 2 PO 4 , 3.5 MgSO 4 , 0.5 CaCl 2 , 26 NaHCO 3 , and 10 glucose, pH 7.4 with HCl. Mice were quickly decapitated, and whole brains were dissected into cold oxygenated SSS. Coronal brain slices (350 m) were cut in a vibratome in cold oxygenated SSS and transferred to recover in oxygenated SSS at room temperature for 45 min. Slices were then allowed to recover for at least 1 h at room temperature in oxygenated aCSF (as above, except with 30 mM glucose) before transferring to the recording chamber. During recording, slices were superfused with 30 mM glucose aCSF at 30°C.
Loose-seal cell-attached recordings from vMHb neurons were obtained using the blind-patch technique in slice preparations using brightfield optics to visualize the habenula. Cholinergic neurons expressing ChR2 in the vMHb of Chat Cre /Ai32 mice were identified based on the presence of light-induced action potentials. Recording electrodes (3-7 M⍀) were filled with 10 mM glucose aCSF, and recordings were obtained with a MultiClamp 700B Amplifier (Molecular Devices), connected to a digitizing interface (Digidata 1440), and analyzed with pClamp 10.2. For patch-clamp recording from cholinergic neurons in the vMHb and ␣5 GFP neurons in the IP, electrodes (3-7 M⍀) were filled with an internal solution containing (in mM) 140 K-gluconate acid, 1 CaCl 2 , 2 MgSO 4 , 10 EGTA, 4 Na 2 -ATP, 0.3 Na-GTP, and 10 HEPES, pH 7.2. In whole-cell voltage clamp mode, vMHb neurons were held at Ϫ60 mV and IP neurons at Ϫ80 mV. A low-pass filter (250 Hz) was applied to selective records to remove movement artifacts. Optical stimulation of brain slice preparations to activate ChR2 was supplied by a 447 nm blue laser (OptoEngine) coupled to a 200 m, 0.22 NA optical fiber (Thor Labs). The optical fiber was submerged in aCSF with its bare fiber end placed 5 mm from the habenula (2.0 mW/mm 2 ) or 2 mm (9.7 mW/ mm 2 ) from the IP. For drug application, DNQX (10 M), D-AP-5 (50 M), dihydro-␤-erythroidine hydrobromide (DH␤E; 10 M), SR16584 (20 M), and mecamylamine (5 M) were bath applied to the circulating aCSF by diluting a stock solution. Standardized pulses of nicotine (0.5 M) were applied by controlled positive-pressure pulses, delivered through a picospritzer and a pulled glass pipette. All drugs were purchased from Tocris Bioscience.
To assess for a synaptic connection between vMHb neurons and ␣5-expressing neurons in the IP, coronal sections were prepared from Chat Cre /Ai27, ␣5 GFP or Chat Cre /Ai32, ␣5 GFP transgenic mice at a plane of section containing vMHb fiber terminals and rostral IP (IPR) cell bodies (bregma, Ϫ3.4 Ϯ 0.2 mm). Neurons expressing ␣5 GFP were identified for recording using epifluorescence of the cytoplasmic GFP marker. Before laser stimulation, a 2 min continuous recording was performed to determine baseline activity, followed by 100 -150 control traces consisting of 1 s recordings with a 2 s intersweep interval between recorded traces. For the laser stimulation protocol, identical 100 -150 1 s traces were recorded, but with a 10 ms laser pulse at the beginning of each trace. The role of glutamatergic signaling was tested by bath application of the glutamatergic inhibitors DNQX and D-AP-5, and the laser stimulation protocol was repeated 10 min after drug application. Each slice was used for one to three recordings; for slices from which multiple cells were recorded, aCSF was superfused for at least 30 min between recordings to wash out the applied drugs. Recordings were manually scored for the presence of EPSCs, EPSC latencies, and amplitudes from 0 to 13.9 ms after the onset of the 10 ms laser pulse, in both laser-stimulated and control traces. A 60 -80 s recording before light stimulation was used to calculate the mean baseline amplitude. EPSCs with amplitudes Ͻ2 SDs from the mean baseline amplitude were assumed to be noise and were not included in the analysis. To determine the nicotinic receptor pharmacology of ␣5 GFP neurons in the IP, coronal sections were prepared from ␣5 GFP transgenic mice. For pharmacological studies of nicotine responses in the vMHb, coronal sections were prepared from Chat Cre /Ai32 transgenic mice, which express an EYFP marker in cholinergic neurons in the vMHb, allowing these cells to be identified for patch-clamp recording in the slice preparation by fluorescence microscopy. The ␣5 GFP IP neurons were similarly identified in coronal sections by their GFP fluorescence. Nicotine (0.5 mM) was pressure applied in brief pulses (90 ms, 10 -12 psi) every 3 min to avoid receptor desensitization, using established methods . Once the cells reached a stable response to the nicotine application, four to six inward current responses were averaged to be the baseline response before bath application of the antagonist. Responses to the antagonist were assessed beginning 10 min after application, and three to nine current responses were acquired once the nicotine response of the cells stabilized in the presence of the antagonist. Responses to drug recovery were assessed 10 or 30 min after switching to aCSF. The average nicotine-evoked current during antagonist application and recovery was normalized to the average baseline nicotineevoked current for each neuron. Since effects of mecamylamine and DH␤E are reversible, brain sections were reused once for those experiments after at least 30 min of washout in aCSF. Fresh brain sections were used for SR16584 experiments.
Statistical analyses. Paired t tests were used for analyzing the effects of light-evoked EPSCs recorded from individual ␣5 GFP IP neurons. The Friedman test and the Dunn's multiple comparisons test were used for analyzing the effects of mecamylamine and SR16584 on nicotine responses in vMHb neurons. Wilcoxon tests were used for analyzing the effects of DH␤E and SR16584 on nicotine responses from individual ␣5
GFP IP neurons. Statistical analyses were performed using GraphPad Prism 6 software. Results are presented as means (SD).
Results
Identity of nAChR ␣5 subunit-expressing neurons in the habenulo-peduncular-tegmental system
Identification of the specific neurons in which the ␣5 nAChR subunit is expressed is essential for two principal reasons. First, because it is an accessory subunit, the effect of ␣5 on nAChR function depends entirely on the specific channel-forming/ ligand-binding subunits with which it is assembled Ramirez-Latorre et al., 1996; Nelson and Lindstrom, 1999) , and the available partners are cell specific. Second, cellular resolution is necessary to identify ␣5-expressing neurons in brain nuclei containing diverse cell types, such as the IP and MnR, to understand how these neurons may assemble into functional circuits. Three principal methods have been used to describe the expression of nAChRs in the brain: in situ hybridization, receptor autoradiography, and receptor binding in brain homogenates, which have not provided cellular resolution. There are no published reports of ␣5 subunit localization by immunohistochemistry, presumably because the available antibodies are not suitable for this purpose. Here, we have overcome these limitations by using an ␣5 GFP BAC transgene (GENSAT), examined by immunofluorescence for the expressed GFP and by cellular-resolution FISH to examine the neurotransmitter phenotype and circuitry of ␣5-expressing neurons in the brainstem.
To understand the expression of ␣5 at the cellular level, we first examined the expression of a GFP reporter in ␣5 GFP mice and compared it with the pattern of ␣5 mRNA in the ABA. In the telencephalon, ␣5
GFP -labeled cell bodies were observed in the neocortex (layers 5 and 6), endopiriform nucleus, subiculum, and CA1 region of the hippocampus (Fig. 1A-F and data not shown), entirely in agreement with ABA data. In contrast, no cell body or fiber staining was noted in the medial or lateral habenula (LHb; Fig. 1G,I ), also in agreement with ABA data. However, the ␣5 GFP transgene did not replicate the known expression of ␣5 mRNA in the VTA and substantia nigra (Fig. 1J-L; . This specific lack of expression of ␣5 GFP in these midbrain dopaminergic nuclei could occur because the required Chrna5 gene regulatory sequences lie outside the BAC used to generate the transgene. Axonal transport of GFP also allowed visualization of the major projections of the ␣5 GFP neurons. Fiber labeling, but no cell bodies, were seen prominently in thalamic regions, including the laterodorsal, central medial, ventrolateral, and ventromedial nuclei, representing the expected projections of the cortical layer 5-6 neurons (data not shown).
Numerous ␣5 GFP cell bodies were observed in the IP, consistent with database ISH data ( Fig. 2A-C) . The ␣5 GFP -labeled cells were concentrated in the IPR, encompassing part of the region that receives intense cholinergic input from the vMHb (Fig.  2 
B, D-F ). Occasional ␣5
GFP cells were also observed in the caudal IP (IPC) but not in the lateral IP (IPL), which receives SPimmunoreactive fibers from the dorsal MHb (Fig. 2G,H ) . The most caudal part of the IP contained few ␣5 GFP neurons (Fig. 2I ), but at this level, scattered cells and GFP fiber staining were observed in the MnR.
The ␣5 GFP -expressing neurons were also detected more caudally in the brainstem in the MnR and adjacent PMnR and in the DRI (Fig. 3A-I ) but not in the principal part of the dorsal raphe or the central nucleus of the dorsal tegmentum (DTgC). In the raphe areas where they were observed, ␣5
GFP neurons were distinct from, but adjacent to, the serotonergic cell population marked by the expression of the enzyme Tph2 (Fig. 3C, E, H ). In the laterodorsal tegmental nucleus (LDTg), ␣5
GFP neurons were seen to be intermingled with the cholinergic neurons that characterize this region ( Fig. 3 J, K ). The most caudal expression of ␣5 GFP was in the posterior dorsal tegmental nucleus (PDTg; Fig.  3L -N ). In each of these brainstem areas, there was strong correlation between the distribution of the ␣5 GFP signal and ␣5 mRNA expression.
Expression of the Chrn␣3/␤4/␣5 gene family in the habenulopeduncular system The MHb has been proposed as a critical site of action of the ␣5 receptor subunit in nicotine-related behaviors, yet ␣5 GFP was not detected in this nucleus, even with immunofluorescent enhancement of the GFP signal. Prior studies have reported mixed findings on the expression of ␣5 mRNA in the MHb. The initial report of ␣5 cloning in the rat showed ␣5 mRNA expression in lamina 5-6 of the neocortex, the subiculum, IP, ventral tegmental area (VTA), and substantia nigra, pars compacta (SNc) of the adult rat but reported that it was not detected in the MHb (Boulter et al., 1990). Subsequent in situ hybridization studies using the same rat full-coding probe in mouse tissue reported low levels of ␣5 mRNA expression in the MHb (Marks et al., 1992; Winzer-Serhan and Leslie, 2005; Heath et al., 2010) . Studies using fullcoding probes for ␣5 in the MHb, especially across species, should be interpreted with caution because ␤2, ␤3, ␤4, and ␣3 transcripts are also expressed in this nucleus (Allen Institute for Brain Science, 2012), and cross-hybridization must be considered. Thus, to reconcile ␣5 GFP expression with that of the endogenous gene, we reexamined expression of the ␣5 mRNA by in situ hybridization and compared expression of the clustered Chrna3/ b4/a5 gene transcripts by qPCR in the brain regions of interest.
To design a probe with complete specificity for ␣5, we amplified ␣5 cDNA fragments from the CDS and the 3Ј-UTR from adult mouse interpeduncular nucleus RNA by RT-PCR (Fig. 4A ). To verify that the predicted 3Ј-UTR sequence was transcribed at levels similar to the coding part of the ␣5 transcript, we compared the expression of the 3Ј-UTR and coding sequences by qPCR (see Materials and Methods). Expression levels of the coding and noncoding sequences matched within one to two amplification cycles. Nonisotopic in situ hybridization with the ␣5 CDS and 3Ј-UTR probes gave a strong signal in the IP (Fig. 4B-D) . Neither probe alone, nor a combination of the probes, gave a detectable signal in the MHb (Fig.  4E) .
In a previous study, we used microarrays and bioinformatic analysis of the E16.5 MHb to detect transcripts enriched in the MHb relative to other brain regions and genes that are developmentally regulated in the MHb by the transcription factor Brn3a, encoded by the Pou4f1 gene (Quina et al., 2009 ). The microarrays used in these studies provide independent expression data for most of the nAChR subunits (Fig. 4F ) . At E16.5, ␣3 and ␤4 transcripts are robustly expressed and are markedly decreased in the Pou4f1 knock-out. Both ␣5 probe sets on the array, one corresponding to the CDS and one encompassing the 3Ј-UTR, showed undetectable levels of expression.
To better quantify the relative expression of ␣5 mRNA in the adult brain regions of interest, we performed qPCR using primer pairs specific for ␣3, ␤4, and ␣5 transcripts (Fig. 4G,H ) . Expression of ␣5 mRNA in the MHb was ϳ3.5% of that observed in the IP. Although low, this ratio probably still overestimates the cellspecific expression of ␣5 in the MHb relative to the IP because the cells sampled in the MHb are much more homogenous. The fraction of cells expressing ␣5 in the MHb sample could not be estimated because expression could not be detected at the cellular level. Conversely, ␣3 and ␤4 mRNA levels in the IP were only ϳ2% and ϳ3% of the MHb levels, respectively. We conclude that the absence of detectable GFP expression in the MHb of ␣5 GFP mice is consistent with the very low levels of ␣5 mRNA expressed GFP (J, K ) and ␣5 (L) mRNA in the VTA. Immunofluorescence for tyrosine hydroxylase reveals the location of the dopaminergic neurons in the VTA. In situ hybridization views are derived from the ABA dataset. CA1, Hippocampus region CA1; cc, corpus callosum; CPu, caudate/putamen; dMHb, medial habenula, dorsal part; L5-6, cortical lamina 5-6; SNC, substantia nigra, pars compacta; SNR, substantia nigra, pars reticulata. there and is not attributable to an artifact of low ␣5 GFP transgene expression. While mRNA abundance does not perfectly predict receptor expression caused by possible post-transcriptional effects on protein levels, it is thus likely that ␣5 subunits are much more abundant in the IP than in the MHb.
Neurotransmitter phenotypes of ␣5-expressing neurons
To understand the role of ␣5-expressing neurons in regulating behavioral pathways, we next examined the principal neurotransmitter phenotype of these cells. None of the ␣5-expressing cell groups in the CNS expressed ChAT (Fig.  3J-N and data not shown), indicating that ␣5-expressing neurons are not themselves cholinergic and that the ␣5 subunit is integrated into postsynaptic receptor complexes, not presynaptic autoreceptors. In the SNc and VTA, the anatomical expression pattern of ␣5 mRNA is consistent with expression in dopaminergic neurons (Boulter et al., 1990) , but this was not assessed directly because the ␣5 GFP transgene was poorly expressed in this region. In the remainder of the brainstem, ␣5
GFP did not colocalize with tyrosine hydroxylase (dopaminergic, noradrenergic neurons) or Tph2 (5-HT neurons), indicating that is not expressed in monoaminergic cells outside of the SNc/VTA (Fig. 3A-H and data not shown).
To determine the principal neurotransmitter phenotype of ␣5-expressing neurons throughout the neural axis, we used DFISH (Thompson et al., 2008) to examine the coexpression of ␣5 mRNA with the GABAergic marker Gad1(Gad67), the brainstem glutamatergic marker Slc17a6 (Vglut2), and the neuropeptide cotransmitter somatostatin (Sst). In the forebrain, ␣5
ϩ layer 5-6 cortical neurons that project to the thalamus are, as expected, Gad1 negative and therefore glutamatergic (data not shown). The ␣5 ϩ neurons in the ventral subiculum also show no overlap with the Gad1 ϩ interneuron population there (Fig. 5A) .
In the IP, essentially all ␣5 ϩ neurons were also Gad1 ϩ (Fig.  5B) . Conversely, most GABAergic neurons in IPR were ␣5
ϩ , but GABAergic neurons in IPC and IPL were mostly ␣5 negative. Although Slc17a6 ϩ neurons were intermingled with ␣5 ϩ neurons in the IPR, colocalization of these markers was not observed (Fig. 5C) . Likewise in the MnR/PMnR and DRC/DRI, where ␣5 ϩ cells lie adjacent to 5-HT neurons, essentially all of the ␣5 ϩ neurons also expressed Gad1 (Fig. 5D) . We conclude that in the brainstem, ␣5 expression defines a subset of GABAergic neurons.
In the neocortex, subclasses of GABAergic neurons have been distinguished by the expression of the calcium-binding proteins parvalbumin and calretinin and by neuropeptides, particularly Sst, vasointestinal active peptide, and cholecystokinin (Xu and Callaway, 2009). We examined these markers using DFISH and immunofluorescence in ␣5 GFP mice to determine whether they also distinguish subsets of GABAergic neurons in the IP or colocalize with ␣5. A small number of neurons in the most dorsal part of the IPR coexpress Sst and ␣5 mRNA (Fig. 5E) . Parvalbumin immunoreactivity identifies a subset of IP neurons, but these are ␣5 GFP negative (Fig. 5F ), whereas anti-calretinin antisera stained afferent fibers but not cell bodies in the IP (data not shown). Brn3a is also expressed in a subset of neurons in the IPR and IPL, but these are ␣5 GFP negative (Fig. 5G) .
Projections of ␣5 neurons link the IP and raphe
To begin to understand the function of ␣5-expressing neurons in the IP, MnR, and DTg, we used transgenic anterograde tract tracing and retrograde tracing with CTB to identify the principal connections of these neurons. Transgenic tracing of ␣5 GFPlabeled IP neurons shows that their axons project through the MnR to the DTg, both of which also include intrinsic ␣5 neurons (Fig. 6A) . Thus, anterograde tracing of GFP-labeled fibers does not immediately reveal whether ␣5-expressing IP neurons project all the way to the DTg or terminate at intermediate targets. It is also not clear whether the ␣5 neurons in the MnR and DTg project rostrally, caudally, or locally.
We then used stereotaxic injections of CTB to determine the specific projections of the ␣5-expressing neurons in the brainstem. CTB is a strong retrograde tracer but will also label fibers in an anterograde direction, yet it appears to label fibers of passage weakly or not at all (Luppi et al., 1990 ). Retrogradely labeled neurons were unambiguously identified by colocalization of CTB with GFP, which fills the cytoplasm of ␣5 GFP neurons, using confocal microscopy. Injection of CTB into the MnR (Fig. 6B) led to frequent labeling of ␣5-expressing neurons in the IPR (Fig.  6C,D) . Injection of the DTg at the midline (Fig. 6E) , an area that is populated with 5-HT neurons of the DRC/DRI, also led to frequent colabeling with ␣5 GFP in the IPR (Fig. 6 F, G) and MnR (data not shown), confirming that ␣5-expressing IPR and MnR neurons project directly to this region. In single (1 m) confocal sections, the profiles of IPR ␣5 GFP neurons retrogradely labeled from the MnR and DTg revealed cell bodies typically 15-20 m in diameter that were often most intensely labeled with CTB at one pole, probably representing the origin of the axon (Fig.   6 H, I ). We note that a large fraction of the CTB-labeled neurons in IPR were ␣5 GFP negative, consistent with the fact that ␣5 GFP is expressed in only a subset of the IPR neurons. The ␣5 GFP /CTB doublelabeled neurons were smaller than some of the CTB-labeled cells that did not express ␣5 GFP , consistent with the identity of the ␣5 GFP neurons as GABAergic interneurons (Fig. 5) , which frequently have relatively small somas. We also note that many ␣5
GFP neurons remained unlabeled in each of these retrograde labeling cases. This is the expected result from a small, focal injection that only labels part of the overall IPR terminal field in MnR, DR, and DTg. In contrast, more lateral injections in the DTg (Fig. 6J ) , overlapping the region of the LDTg that contains cholinergic neurons (Fig. 6K ) but avoiding the DRI (Fig. 6L) , seldom labeled ␣5 GFP neurons in the IPR. Instead, retrograde labeling was seen in the dorsolateral IP (IPDL), mainly contralateral to the injection (Fig.  6M,N) . This region did not stain for ␣5 GFP and could be distinguished from the adjacent IPL by its lack of SP expression. Together, these data demonstrate that ␣5-expressing neurons in the IP terminate near 5-HT neurons throughout the MnR and DRC/DRI but represent only one class of IP neurons that terminate in these areas, intermingled with more numerous non-␣5 GFP cells. In addition to the ␣5 GFP cell bodies in the IPR, we also noted GFP fiber staining in the IP, especially in IPC (Figs. 2G, 6M ), suggesting that ␣5 neurons also supply afferents to the IP. Injections of CTB into the IP (Fig.  7A ) produced intense labeling of both fibers (anterograde labeling) and cell bodies (retrograde labeling) in the MnR (data not shown) and the DTg/DRI (Fig. 7B,D) . Confocal imaging of retrogradely transported CTB and ␣5 GFP revealed that ␣5 neurons in the PDTg (Fig. 7C ) and in the region surrounding the 5-HT neurons of the DRI (Fig.  7E,F) project to the IP. Thus, ␣5
GFP neurons in the IP and the MnR/DRI form reciprocal connections between these regions (Fig. 7G) .
Optogenetically assisted circuit mapping of the vMHb connection to ␣5-expressing IP neurons
Previous work has shown that vMHb neurons use both glutamate and acetylcholine as coneurotransmitters but that fast synaptic connections to IP neurons are mediated mainly by glutamate (Ren et al., 2011) . The identities of the postsynaptic IP neurons recorded were not specifically characterized in this study. To assess the synaptic connection between vMHb neurons and ␣5 GFP neurons in the IP, we used optogenetically assisted circuit mapping. Specific expression of ChR2 in the vMHb was accomplished using a recently described Cre-inducible expres- array probe sets, and in situ hybridization probes to the Chrna5 coding sequence and 3Ј-untranslated region. B-E, In situ hybridization for ␣5 mRNA using individual and combined probes in the interpeduncular nucleus (B-D) and habenula (E). F, Microarray assay of cholinergic receptor subtype mRNA expression in the E16.5 mouse habenula (medial plus lateral). Values shown are means of two independent experiments for each genotype. Null signs indicate "absent" calls, and asterisks indicate significant probability of change values using the Affymetrix MAS5.0 analysis platform, as described previously (Quina et al., 2009) . Two probe sets for ␣5, A:1427401_at (␣5C) and B:1442035_at (␣5-3Ј), appear on the array, neither of which has a signal above the detection threshold. The ␣3, ␣4, and ␤4 are significantly decreased in the habenula of Brn3a null mice. G, Real-time qPCR assays of regional brain expression of ␣3, ␤4, and ␣5 mRNA in the hippocampus (CA1), cerebellum (Cb), cerebral cortex layers 2-4 (Ctx2-4), cerebral cortex layers 5 and 6 (Ctx5-6), MHb, and IP. Results were scaled such that expression in the highest-expressing tissue equals 100%. Dashed bars for Chrna5 expression indicate values adjusted for the lower fraction of ␣5 GFP -expressing neurons in cortical layers 5 and 6 and the hippocampus relative to the IPN, to approximate the level of expression per ␣5-expressing cells. H, Location of dissected tissues from vibratome sections used to prepare RNA for qPCR assays of nAChR expression. Cerebellum tissue was harvested as a block. Scale bars: B-E, 100 m. sion system based on microbial opsin genes targeted to the Gt(ROSA)26Sor locus (Madisen et al., 2012) . In this study, we used the transgenic lines Ai27, which allows inducible expression of a Channelrhodopsin2(H134R)-tdTomato fusion gene product (ChR2-tdTomato), and Ai32, which allows expression of a ChR2-EYFP fusion gene product. Ai32 conferred somewhat higher light sensitivity, but the performance of the two ChR2 fusion proteins in electrophysiological experiments was similar. Expression of each ChR2 allele was induced by interbreeding with a Chat
Cre driver line containing an IRES-Cre expression construct targeted to the 3Ј-untranslated region of the Chat gene (Rossi et al., 2011) . In mice with Chat
Cre induction of ChR2, expression of the transgene was confined to the vMHb, with sparing of the dorsal MHb and the LHb (Fig. 8A) . In the IP, ChR2-labeled fibers were confined to the rostral and caudal parts of the IP (Fig. 8B ), known to be the termination zone of cholinergic vMHb fibers (Eckenrode et al., 1987; Quina et al., 2009 ). For optogenetic circuit mapping, experimental animals had the genotype Ai27 (or Ai32), Chat
Cre , or ␣5 GFP . The ␣5 GFP -expressing IP neurons were readily visualized using GFP fluorescence in vibratome sections of brain tissue prepared for electrophysiology (Fig. 8C) .
To test light activation of ChR2-expressing vMHb neurons, we first used loose-seal, cell-attached current-clamp recordings from vMHb cell bodies (Fig. 8D) . At baseline, neurons in the vMHb exhibited slow, irregular tonic firing, consistent with previous reports of spontaneous habenula activity (Kim and Chang, 2005) . Trains of blue light pulses elicited 1:1 spiking of action potentials from vMHb neurons at frequencies of up to ϳ10 Hz (Fig. 8D) . We then used whole-cell voltage-clamp recordings to measure light-evoked EPSCs in ␣5-expressing IP neurons. In oblique slice preparations that contained the intact habenulopeduncular system, including the vMHb, fasciculus retroflexus, and IP, very frequent spontaneous EPSCs were observed in IP neurons, presumably because of network activity (data not shown). To better isolate the light-evoked EPSCs caused by specific synaptic connections between the vMHb and the IP, experiments were performed in coronal sections through the IP, which included only the fiber terminals and not the cell bodies, of the vMHb glutamatergic/cholinergic neurons.
Light-evoked EPSCs recorded from individual ␣5
GFP IP neurons frequently showed multiple consistent latencies and amplitudes, suggesting multiple vMHb synaptic inputs to a single cell (Fig. 8E) . These light-evoked EPSCs generally occurred with latencies of 5-11 ms from the onset of a 10 ms light pulse. Median latencies of 5, 6.2, 6.5, 6.5, 8.5, and 9 ms were observed for the six cells characterized (the cell with a median latency of 9 ms is shown in Fig. 8F ). The median latencies exhibited by these neurons are within the typical latencies for monosynaptic transmission elicited by optogenetic excitation of axon terminals across several studies (Piñol et al., 2012) . In the sample of cells recorded, the probability of an EPSC occurring in the interval from 3 to 11 ms after a light pulse ranged from 0.16 to 0.94, compared with 0.01-0.15 for matched time intervals without laser stimulation ( p ϭ 0.01, paired t test; n ϭ 6; Fig. 8G ). Both spontaneous and light-evoked EPSCs were entirely blocked by inhibitors of glutamatergic signaling (DNQX and D-AP-5), consistent with a previous study showing that glutamate mediates the fast synaptic connection from the vMHb to IP (Ren et al., 2011) . We conclude that the vMHb and ␣5-expressing IP neurons form a direct synaptic circuit in which glutamate is the principal fast neurotransmitter. These results are consistent with a "neuromodulatory" role for acetylcholine in the IP, as described in other CNS regions .
Nicotinic receptor pharmacology of ␣5
GFP neurons in the IP The habenulopeduncular system has been hypothesized to regulate behavioral responses to nicotine. Because ␣5 is an accessory receptor subunit, the other ␣ and ␤ nicotinic receptor subunits with which it interacts will determine the ligand-binding and ion channel properties of ␣5-containing receptors. In most areas of the brain in which it is expressed, ␣5 is likely to complex with the widely expressed receptor subunits ␣4 and ␤2. However, it is unclear what subunits would interact with ␣5 in the IP and, specifically, whether sufficient ␣3 and ␤4 subunits are expressed to allow for the possible formation of functional ␣3␤4 complexes containing ␣5 subunits. The principal nAChRs reported from ligand-binding studies of IP homogenates contain ␣3␤4 and Figure 5 . Neurotransmitter phenotype of ␣5-expressing neurons. DFISH (A-E) and immunofluorescence (F, G) were used to determine the colocalization of ␣5 mRNA with other markers in the IP and MnR. A, In the subiculum, ␣5 does not colocalize with Gad1, indicating that the ␣5 ϩ neurons in this region are glutamatergic. Similar results were observed in layer 6 of the neocortex (not shown). B, In the IPR, Ͼ95% of ␣5 ϩ neurons also express Gad1. C, DFISH for ␣5 and Slc17a6 (Vglut2) mRNA shows no colocalization in IPR, although glutamatergic neurons are present in the nucleus. D, In the MnR/PMnR, Ͼ95% of ␣5 ϩ neurons coexpressed Gad1. The dashed line indicates the midline. E, A small number of ␣5 ϩ neurons in the apex of IPR were seen to coexpress Sst. F, The ␣5 ϩ neurons are negative for parvalbumin, which identifies a distinct subset of IPR neurons. G, The ␣5 ϩ neurons are negative for the transcription factor Brn3a, which is expressed in a distinct population of IPR and IPL neurons. AЈ-EЈ, Enlargements of boxed areas in accompanying images. Sub V , subiculum, ventral. Scale bars, 100 m. GFP ; rostral is on the left. Lines show the planes of section for the injections shown in B, E, H, and Figure 7A . B, Location of injection site in MnR/dorsal raphe (plane of section at bregma, Ϫ4.4). C, D, Retrograde labeling of IPR neurons from MnR. In D, a Z-stack of 20 1 m optical sections is shown, and arrows indicate neurons double labeled for CTB and GFP (see also H ). E, Location of injection site in the midline of the DTg (bregma, Ϫ5.3), an area populated with 5-HT neurons of the DRC/DRI, which can be seen in Figure 3H . GFP neurons. 4V, Fourth ventricle; 7n, facial nerve; Aq, aqueduct; Cb, cerebellum; DR, dorsal raphe; IC, inferior colliculus; IPF, interpeduncular fossa; LC, locus ceruleus; LDTgV, lateral dorsal tegmental nucleus, ventral; mcp, middle cerebellar peduncle; mlf, medial longitudinal fasciculus; MM, medial mammillary nucleus; Mo5, motor trigeminal nucleus; PAG, periaqueductal gray; Pn, pons; PnC, pontine reticular nucleus, caudal; PnR, pontine raphe nucleus; Pr5, principal trigeminal nucleus; Pr5DM, principal trigeminal nucleus, dorsomedial; Pr5VL, principal trigeminal nucleus, ventrolateral; py, pyramidal tract; R, red nucleus; RLi, rostral linear nucleus of raphe; s5, sensory root of 5 n; SC, superior colliculus; scp, superior cerebellar peduncle; SNC, substantia nigra, pars compacta; SNR, substantia nigra, pars reticulata; SO, supraoptic nucleus; vtgx, ventral tegmental decussation; xscp, decussation superior cerebellar peduncle ventral part. Scale bars: B, E, J, 400 m; C, F, 200 m; D, G, K-N,100 m; H, I , 25 m. ␣4(or ␣2)␤2 (Grady et al., 2009) . Autoradiographic binding studies of nicotinic receptor knock-out mice show ␤4-containing receptors are required for much but not all of IP nicotinic ligand binding (Baddick and Marks, 2011) . However, ligand binding in the IP may be contributed by either the presynaptic vMHb fiber terminals or the postsynaptic IP neurons, and these cannot be resolved by ligand-binding studies in homogenates or autoradiography. Instead, to determine the likely subunits associated with ␣5
GFP in the IP, we took an electrophysiological approach, using pulsed application of nicotine combined with specific inhibitors of nAChR subtypes. First, however, we considered whether the use of the ␣5 GFP BAC transgene might lead to the mis-expression of ␣3 and ␤4 nAChR subunits, because of the genomic clustering of the Chrna3, Chrnb4, and Chrna5 genes that are all encompassed within the parent BAC. Because ␣3 and ␤4 are cotranscribed on the same strand, we chose to examine ␤4 mRNA expression by in situ hybridization in the MHb and IP. The ␤4 expression appeared to be increased in the vMHb of ␣5 GFP mice relative to controls (Fig. 9A,B ) but was unchanged in the IP, where only a faint signal could be detected (Fig. 9C,D) . This demonstrates that the fidelity of tissuespecific gene expression from this BAC transgene is maintained for the transgenic copies(s) of the Chrnb4 gene and that use of the ␣5 GFP BAC transgene as a marker to identify specific IP neurons is unlikely to affect the nAChR subunit composition of those neurons.
To assess the contribution of specific nAChR complexes to nicotine responses in the vMHb and in ␣5 GFP neurons in the IP, we examined nicotine-evoked currents in the presence of DH␤E, a partially selective inhibitor of ␣4␤2-containing receptors, and SR16584 (Zaveri et al., 2010) , a specific inhibitor of ␣3␤4-containing receptors, in the presence of glutamate receptor blockers. To minimize nAChR desensitization known to occur with prolonged nicotine exposure (Covernton and Lester, 2002) , responses were evoked by brief pulsed applications of nicotine every 3 min (90 ms pulse, 0.5 mM nicotine; Fig. 9E -L). Pulsed application of nicotine evoked much stronger currents in cholinergic vMHb neurons than in ␣5 GFP IP neurons. The peak amplitude of the nicotine currents was 1564 Ϯ 1225 pA (range, 633-4076 pA; n ϭ 10 cells) in the vMHb and 297 Ϯ 211 pA (range, 110 -853 pA; n ϭ 16 cells) in the IP. The much greater magnitude of evoked currents observed in the vMHb was not surprising given the high levels of nAChR mRNA known to be expressed there and past studies showing intense nAChR ligand binding in the MHb and its efferent fibers (Harris et al., 1996) .
In vMHb neurons, the broadly specific nAChR inhibitor mecamylamine abolished nearly all of the inward nicotine currents as expected, and this inhibition was partially reversible (Fig. 9 E, G; control, 1398 Ϯ 1097 pA; mecamylamine, 88 Ϯ 29 pA; p Ͻ 0.01, Friedman test and Dunn's multiple comparisons test; n ϭ 4 cells). SR16584 inhibited a majority of these currents in the vMHb (Fig.  9 F, H ; control, 1674 Ϯ 1394 pA; SR16584, 282 Ϯ 127 pA; p Ͻ 0.05, Friedman test and Dunn's multiple comparisons test; n ϭ 6 cells), demonstrating that ␣3␤4-containing nAChRs account for most of the vMHb nicotine response; this inhibitor was poorly reversible in washout experiments. In ␣5 GFP IP neurons, nicotine-induced inward currents were partly inhibited by DH␤E in 6 of 10 of the neurons recorded (Fig. 9 I, K; control, 259 Ϯ 158 pA; DH␤E, 212 Ϯ 155 pA; p Ͻ 0.05, Wilcoxon test; n ϭ 10 cells) and by SR16584 in all neurons recorded (Fig. 9 J, L; control, 360 Ϯ 286 pA; SR16584, 84 Ϯ 69 pA; p Ͻ 0.05, Wilcoxon test; n ϭ 6 cells). These data suggest the presence of both ␣4␤2-and ␣3␤4-containing nAChRs in the IP, either of which could potentially incorporate ␣5 subunits.
Discussion
The cholinergic projection from the MHb to the IP has long been thought to mediate behavioral effects of nicotine, but its exact role has been elusive. Experiments in animal models have shown directly that the habenulopeduncular system plays a role in nicotine withdrawal (Salas et al., 2009 ). The complements of unusual nAChRs expressed in the MHb and IP are candidates for expression incidental to other findings. The sensitivity of the 35 S autoradiographic methods used in these reports is probably higher than the nonisotopic methods used here, or in the Allen Mouse Brain Atlas, leading to detection of this weak signal. Thus, these studies are consistent with our quantitative analysis showing very low levels of ␣5 mRNA in the MHb. We conclude that ␣5 mRNA expression in the MHb is much lower than that of the other nAChR subunits expressed there and much lower than in other brain regions where it has been detected. Indeed, in the MHb the Chrna5/a3/b4 gene locus is transcribed with remarkable specificity for the strand that encodes the ␣3 and ␤4 receptors.
The expression of functional nAChR complexes in the habenulopeduncular system has also been characterized by radioligand binding using autoradiography in tissue sections and by immunoprecipitation of membrane preparations from brain homogenates, most frequently using 3 H-and 125 I-epibatidine, respectively. Although epibatidine binds all nAChR subtypes with high affinity, relatively specific competitors (autoradiography) or precipitation of complexes with specific antibodies (homogenates) can be used to identify receptor subunit composition.
3 Hepibatidine autoradiography has been used to examine Chrna5 null mutant mice, but because ␣5 does not participate in ligand binding, loss of ␣5 does not affect these results. In contrast, loss of the ␤4 subunit has a profound effect on MHb binding of 3 Hepibatidine (Baddick and Marks, 2011), consistent with our results showing marked inhibition of nicotine-evoked currents with the ␣3␤4 inhibitor SR16584. Immunoprecipitation of 125 I-epibatidine-labeled receptors in brain homogenates has the limitation that both presynaptic and postsynaptic membranes are included in the preparation. Thus, in the IP, the contribution of afferent MHb fibers and expression in local IP neurons to overall binding cannot be distinguished. Immunoprecipitation studies have shown variable results for the ␣5 receptor in the habenula. In one study, moderate levels of ␣5 receptor-containing complexes were detected in the rat habenula and low levels in the mouse (Grady et al., 2009) . However, in this study, the ␣5 immunoprecipitation signal from the rat habenula was nearly eliminated by immunodepletion of the preparation with ␤2 receptor antibodies. This suggests that the ␣5-containing receptors in this preparation did not originate in the MHb because autoradiographic studies of the MHb indicate that loss of the ␤2 receptor has a minimal effect on 3 H-epibatidine binding in the MHb (Baddick and Marks, 2011) and that binding there is primarily dependent on the ␤4 receptor. A possible source for receptors containing the ␣5 and ␤2 subunits in habenula samples is the large projection from layer 5-6 cortical neurons that terminates in the dorsal thalamus, immediately ventral to the habenula. The association of ␣5 and ␤2 subunits in functional receptors from this region has been shown (Heath et al., 2010) . A more recent immunoprecipitation study showed very low levels of ␣5-containing receptor complexes in the habenula (MHb plus LHb) of postnatal day 18 rat and mouse (6% of 3H-epibatidinebinding receptors in mice and 2.5% in rats; Scholze et al., 2012) , consistent with our quantitative mRNA expression data.
We conclude that it is not likely that the ␣5 subunit forms stoichiometric complexes with the abundant ␣3␤4 nAChRs in the MHb. Although it has been established in multiple laboratories that loss of the ␣5 receptor results in nicotine-related behavioral changes (Salas et al., 2003 (Salas et al., , 2009 Gangitano et al., 2009; Fowler et al., 2011) , these effects probably do not result from the loss of ␣5 function in the MHb. We also conclude that the behavioral effects reported after the use of viral vectors to drive ␣5 expression in the MHb of ␣5 knock-out mice (Fowler et al., 2011) or of ␤4-overexpressing mice (Frahm et al., 2011) are likely to result from the nonphysiological expression of this subunit, not a "rescue" of normal function. Instead, in the habenulopeduncular pathway, ␣5-expressing IP neurons are more likely to mediate the effects of the ␣5 knock-out. Also, expression studies showing ␣5 mRNA in the VTA/SN (Azam et al., 2002) and ␣5 receptors on DA terminals in the striatum (Zoli et al., 2002) , combined with recent work showing alterations in evoked DA release in the dorsal striatum of ␣5 knock-out mice (Exley et al., 2012) , suggest that some ␣5 behavioral effects may be mediated by the nigrostriatal pathway. Ultimately, the definitive site of action of the ␣5 subunit in behavioral responses to nicotine may only be resolved by the conditional deletion of Chrna5 in specific brain regions.
As an "accessory" subunit, ␣5 lacks intrinsic channel-forming or ligand-binding ability. Thus, the identity of the available channel-forming ␣-and ␤-subunit partners for the formation of functional pentameric receptors is essential to ␣5 function. Here we have shown that specific inhibitors of both ␣3␤4-and ␣4␤2-containing receptors reduce nicotine-induced currents in ␣5 GFP IP neurons. Significant inhibition by the ␣3␤4 antagonist SR16584 is somewhat surprising given the very low levels of ␤4 mRNA detected in the IP (Fig. 4) . However, in these experiments, high concentrations of nicotine were applied (0.5 M) to intentionally maximize activity of the relatively low-affinity ␣3␤4 receptors. Furthermore, the absolute magnitude of the SR16584-inhibitable current is much greater in the vMHb than in ␣5 GFP IP neurons, consistent with the higher expression of ␣3 and ␤4 mRNA in the vMHb. Finally, we cannot rule out inhibitory activity of SR16584 on receptor complexes other than ␣4␤2 and ␣3␤4, on which it has not been tested (Zaveri et al., 2010) . The inhibitor data presented here are otherwise consistent with prior in situ hybridization data that show expression of the widely distributed ␣4 and ␤2 receptors in the IP, and also the more restricted ␣2 and ␣3 subunits (Wada et al., 1989; Marks et al., 1992) . In 3 H-epibatidine-binding studies, competition of binding with specific inhibitors (Perry et al., 2002; Baddick and Marks, 2011) , combined with knock-out studies (Baddick and Marks, 2011) , also suggests that the IP contains predominantly presynaptic ␣3␤4 receptors expressed on afferent MHb fibers and ␣4␤2 receptors expressed on postsynaptic IP neurons. The relevance of the probable IP ␣4␤2␣5-containing receptor complexes to nicotine-related behaviors is supported by the observation that the smoking-associated human ␣5 variant, D398N, increases receptor desensitization when incorporated into (␣4␤2) 2 ␣5 receptor complexes, but not into (␣3␤4) 2 ␣5 or (␣3␤2) 2 ␣5 complexes (Kuryatov et al., 2011) .
The expression of the ␣5 receptor on GABAergic interneurons in the IP and MnR suggests a possible role for ␣5-expressing neurons in modulating some of the behavioral effects of nicotine. These effects may extend beyond the known role of the ␣5 receptor in mediating the aversion to high doses of nicotine that is lost in the ␣5 null mouse. A major reason cited by smokers for nicotine use is the anxiolytic effect of nicotine, or "stress relief" (Bruijnzeel, 2012) . However, in rodents, nicotine can have either anxiolytic or anxiogenic effects, depending on the dose, timing of administration, and behavioral model used Morissette et al., 2007) . It is likely that these variable effects are attributable to the distribution of nAChRs in many brain regions and the ability of nicotine to cause both activation and desensitization of these receptors. Here we have shown that the expression of the ␣5 subunit characterizes a distinctive population of GABAergic neurons in the IP and raphe whose axonal projections and cell bodies, respectively, have a close relationship to the ventral and caudal parts of the midbrain 5-HT system, particularly the MnR, DRC, and DRI. Neurons in these regions are particularly activated in rodent models of stress (Hale et al., 2012; Spiacci et al., 2012) and in nicotine withdrawal (Sperling and Commons, 2011) . Thus, brainstem ␣5-expressing GABAergic neurons are strong candidates for mediating the anxiolytic effects of nicotine via inhibition of 5-HT neurons in these areas.
